Skip to main content
Livermore
Livermore
ZHEN

Finepoint Capital LP

SEC CIK
0001608126
Latest filing
Aug 13, 2026

Holdings in Q3 2022

Holdings as of Sep 30, 2022, filed Nov 10, 2022. Long positions only; changes compare share counts with Q2 2022.

Institution overview
Positions
57
−3 vs. Q2 2022
Portfolio value
$304.0M
+$14.8M (+5.1%) vs. Q2 2022
Filed
Nov 10, 2022
SEC
Holdings of Finepoint Capital LP in Q3 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
TVTXTravere Therapeutics, Inc.COM1,028,875$25.4M8.3%+444,575+76.1%AddedHistory
ASTLAlgoma Steel Group Inc.COM3,716,732$23.9M7.9%00.0%UnchangedHistory
PRTAProthena Corp Public Ltd CoSHS305,400$18.5M6.1%−152,100−33.2%ReducedHistory
CYTKCytokinetics IncCOM NEW380,793$18.4M6.1%−38,640−9.2%ReducedHistory
ACADAcadia Pharmaceuticals IncCOM1,111,030$18.2M6.0%+403,830+57.1%AddedHistory
APLSApellis Pharmaceuticals, Inc.COM266,090$18.2M6.0%−52,310−16.4%ReducedHistory
ARVNArvinas, Inc.COM399,000$17.8M5.8%+399,000NewHistory
ISEEIVERIC bio, Inc.COM987,600$17.7M5.8%00.0%UnchangedHistory
FOLDAmicus Therapeutics, Inc.COM1,688,400$17.6M5.8%−322,500−16.0%ReducedHistory
RCUSArcus Biosciences, Inc.COM646,586$16.9M5.6%+111,586+20.9%AddedHistory
SAGESage Therapeutics, Inc.COM429,313$16.8M5.5%−46,287−9.7%ReducedHistory
LKFTLakefront Biotherapeutics NVSPON ADR379,702$16.2M5.3%+120,302+46.4%AddedHistory
IOVAIovance Biotherapeutics, Inc.COM1,586,043$15.2M5.0%+625,843+65.2%AddedHistory
CERECerevel Therapeutics Holdings, Inc.COM536,901$15.2M5.0%+536,901NewHistory
DISH Network CORP25470MAF6NOTE 12/1–$13.2M4.3%–New–
ASNDAscendis Pharma A/SSPONSORED ADR123,400$12.7M4.2%−36,100−22.6%ReducedHistory
ARGXArgenx SESPONSORED ADR28,770$10.2M3.3%−24,030−45.5%ReducedHistory
SWTXSpringWorks Therapeutics, Inc.COM308,092$8.79M2.9%+308,092NewHistory
Global Business Travel Group, Inc.37890B118*W EXP 99/99/999913,000$1.43M0.5%00.0%Unchanged–
Bridgetown Holdings LtdG1355U121*W EXP 09/30/202895,000$116.0K<0.1%00.0%Unchanged–
Zimmer Energy Transition Acq989570114*W EXP 06/16/202358,270$111.0K<0.1%00.0%Unchanged–
Conyers Park III Acqsitn Cor21289P110*W EXP 08/12/202571,666$104.0K<0.1%00.0%Unchanged–
Starry Group Holdings, Inc.85572U110*W EXP 99/99/999669,000$87.0K<0.1%00.0%Unchanged–
CNDAWConcord Acquisition Corp II*W EXP 99/99/999408,333$86.0K<0.1%00.0%UnchangedHistory
Churchill Capital Corp VI17143W119*W EXP 02/17/202540,000$76.0K<0.1%00.0%Unchanged–
Churchill Capital Corp VII17144M110*W EXP 02/29/202548,000$74.0K<0.1%00.0%Unchanged–
Summit Healthcre Acquistn CoG8566R110*W EXP 06/03/202489,999$74.0K<0.1%00.0%Unchanged–
Gores Technology Partners II38287L115*W EXP 03/16/202450,691$72.0K<0.1%00.0%Unchanged–
KKR Acquisition Holding I Co48253T117*W EXP 99/99/999588,547$71.0K<0.1%00.0%Unchanged–
Jaws Hurricane Acquisitn Cor47201B111*W EXP 03/26/202387,249$65.0K<0.1%00.0%Unchanged–
Afternext Healthtech AcquisiG01109126*W EXP 99/99/999366,666$59.0K<0.1%00.0%Unchanged–
Ares Acquisition CorporationG33032122*W EXP 99/99/999504,706$58.0K<0.1%00.0%Unchanged–
Fortress Value Acquisi Corp34964K116*W EXP 03/18/202306,513$54.0K<0.1%00.0%Unchanged–
Churchill Capital Corp V17144T115*W EXP 10/29/202612,000$52.0K<0.1%00.0%Unchanged–
Berenson Acquisition Corp. I083690115*W EXP 08/01/202862,499$44.0K<0.1%00.0%Unchanged–
Skydeck Acquisition Corp.G82220115*W EXP 05/13/202361,756$42.0K<0.1%00.0%Unchanged–
Compass Digital Acquisitn CoG2476C123*W EXP 09/29/202459,906$41.0K<0.1%00.0%Unchanged–
Gores Technology Partners IN382870111*W EXP 03/16/202201,000$38.0K<0.1%00.0%Unchanged–
Catalyst Partnrs Acquisitn CG19550121*W EXP 05/12/202336,666$37.0K<0.1%00.0%Unchanged–
CLDWWCalidi Biotherapeutics, Inc.*W EXP 03/14/202655,200$37.0K<0.1%00.0%UnchangedHistory
Bilander Acquisition Corp.09001T114*W EXP 05/19/202183,749$36.0K<0.1%00.0%Unchanged–
Ross Acquisition Corp IIG7641C114*W EXP 02/01/202439,666$34.0K<0.1%00.0%Unchanged–
Fortress Capital Acquisition CorpG36427121*W EXP 99/99/999392,000$31.0K<0.1%00.0%Unchanged–
Corsair Partnering CorpG2540H116*W EXP 07/06/202334,666$28.0K<0.1%00.0%Unchanged–
Swiftmerge Acquisition CorpG63836111*W EXP 12/13/202490,000$25.0K<0.1%00.0%Unchanged–
Fortress Value Acquis Corp I34964G115*W EXP 12/31/202225,000$23.0K<0.1%00.0%Unchanged–
Simon Property Grp Acq Holdi82880R111*W EXP 02/04/202335,200$22.0K<0.1%00.0%Unchanged–
Cohn Robbins Holdings CorpG23726113*W EXP 08/28/202904,000$21.0K<0.1%00.0%Unchanged–
Health Assurn Acquisition Co42226W117*W EXP 11/12/202643,000$19.0K<0.1%00.0%Unchanged–
Revolution Healthcar Aq Corp76155Y116*W EXP 12/31/202432,639$17.0K<0.1%00.0%Unchanged–
Home Plate Acquisition Corp43734R111*W EXP 09/30/202690,000$17.0K<0.1%00.0%Unchanged–
Marblegate Acquisition Corp.56608A113*W EXP 08/31/202735,000$16.0K<0.1%00.0%Unchanged–
Levere Holdings Corp.G5462L122*W EXP 03/09/202274,999$14.0K<0.1%00.0%Unchanged–
Senior Connect Acquisitn Cor81723H116*W EXP 12/31/2021,014,000$10.0K<0.1%00.0%Unchanged–
Warburg Pincus Captal Corp IG9460M124*W EXP 99/99/999125,000$8.00K<0.1%00.0%Unchanged–
The Music Acquisition Corp62752R118*W EXP 02/05/20275,250$3.00K<0.1%00.0%Unchanged–
Warburg Pincus Captal Corp IG9461D115*W EXP 99/99/99914,999$1.00K<0.1%00.0%Unchanged–

Sold out since Q2 2022 (7)

Positions held at the end of Q2 2022 that are gone from this filing.

Positions of Finepoint Capital LP sold out since Q2 2022
SecurityClassShares in Q2 2022Value in Q2 2022% of portfolio in Q2 2022History
SRPTSarepta Therapeutics, Inc.COM211,000$15.8M5.5%History
GBTGlobal Blood Therapeutics, Inc.COM474,000$15.1M5.2%History
MRTXMirati Therapeutics, Inc.COM210,200$14.1M4.9%History
RAREUltragenyx Pharmaceutical Inc.COM203,200$12.1M4.2%History
PTGXProtagonist Therapeutics, IncCOM735,126$5.82M2.0%History
Social Capital Hedosopha HLDG8251L113*W EXP 09/26/202671,000$322.0K0.1%–
Equity Distr Acquisition Cor29465E114*W EXP 09/09/202669,000$69.0K<0.1%–